Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19
Journal of Medical Virology · 2023-02 · 95 (2)
DOI: 10.1002/jmv.28568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 16.02.2023. Verfasst von Vaughn Craddock und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: COVID-19, Extracellular Vesicles. Die Arbeit wurde bisher 130-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
SARS‐CoV‐2, the causative agent of COVID‐19 disease, has resulted in the death of millions worldwide since the beginning of the pandemic in December 2019. While much progress has been made to understand acute manifestations of SARS‐CoV‐2 infection, less is known about post‐acute sequelae of COVID‐19 (PASC). We investigated the levels of both Spike protein (Spike) and viral RNA circulating in patients hospitalized with acute COVID‐19 and in patients with and without PASC. We found that Spike and viral RNA were more likely to be present in patients with PASC. Among these patients, 30% were positive for both Spike and viral RNA; whereas, none of the individuals without PASC were positive for both. The levels of Spike and/or viral RNA in the PASC+ve patients were found to be increased or remained the same as in the acute phase; whereas, in the PASC−ve group, these viral components decreased or were totally absent. Additionally, this is the first report to show that part of the circulating Spike is linked to extracellular vesicles without any presence of viral RNA in these vesicles. In conclusion, our findings suggest that Spike and/or viral RNA fragments persist in the recovered COVID‐19 patients with PASC up to 1 year or longer after acute SARS‐CoV‐2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, Kansas, USA.
ORCID-Profile: Aatish Mahajan
Förderung
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Craddock, V., Mahajan, A., Spikes, L., Krishnamachary, B., Ram, A. K., Kumar, A., Chen, L., Chalise, P., & Dhillon, N. K. (2023). Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19. Journal of Medical Virology, 95(2). https://doi.org/10.1002/jmv.28568
Vancouver
Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al. Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19. Journal of Medical Virology. 2023;95(2). doi:10.1002/jmv.28568
BibTeX
@article{Craddock2023,
author = {Craddock, Vaughn and Mahajan, Aatish and Spikes, Leslie and Krishnamachary, Balaji and Ram, Anil K and Kumar, Ashok and Chen, Ling and Chalise, Prabhakar and Dhillon, Navneet K},
title = {Persistent circulation of soluble and extracellular vesicle‐linked Spike protein in individuals with postacute sequelae of COVID‐19},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {2},
doi = {10.1002/jmv.28568}
}
EUVIMED